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ABSTRACT
Objective To describe the epidemiology of 2009 A/H1N1
influenza in critically ill pregnant women.
Design Population based cohort study.
Setting All intensive care units in Australia and New
Zealand.
Participants All women with 2009 H1N1 influenza who
were pregnant or recently post partum and admitted to an
intensive care unit in Australia or New Zealand between 1
June and 31 August 2009.
Main outcomemeasuresMaternal and neonatal mortality
and morbidity.
Results64pregnant or postpartumwomenadmitted to an
intensive care unit had confirmed 2009 H1N1 influenza.
Compared with non-pregnant women of childbearing age,
pregnant or postpartum women with 2009 H1N1
influenza were at increased risk of admission to an
intensive care unit (relative risk 7.4, 95% confidence
interval 5.5 to 10.0). This risk was 13-fold greater (13.2,
9.6 to 18.3) for women at 20 or more weeks’ gestation. At
the time of admission to an intensive care unit, 22 women
(34%) were post partum and two had miscarried. 14
women (22%) gave birth during their stay in intensive care
and 26 (41%) were discharged from an intensive care unit
with ongoing pregnancy. All subsequently delivered. 44
women (69%) were mechanically ventilated. Of these,
nine (14%) were treated with extracorporeal membrane
oxygenation. Seven women (11%) died. Of 60 births after
20 weeks’ gestation, four were stillbirths and three were
infant deaths. 22 (39%) of the liveborn babies were
preterm and 32 (57%) were admitted to a neonatal
intensive care unit. Of 20 babies tested, twowere positive
for the 2009 H1N1 virus.
Conclusions Pregnancy is a risk factor for critical illness
related to 2009 H1N1 influenza, which causes maternal
and neonatal morbidity and mortality.
INTRODUCTION
Pregnant women are at increased risk of influenza and
its complications.1 The effects of influenza during preg-
nancy have been noted in previous pandemics, parti-
cularly the increased mortality in pregnant women
compared with the general population.2-4 The 2009
influenza A/H1N1 pandemic was the first influenza
pandemic to occur in the era of modern obstetric and
intensive care management,5 and pregnancy is a risk
factor for critical illness due to 2009 H1N1
infection.6-8 Information is, however, limited on medi-
cal and obstetric management andmaternal and infant
outcomes when pregnancy is complicated by 2009
H1N1 related critical illness.
We describe the characteristics, obstetric and inten-
sive care management, and birth outcomes of all preg-
nant and recently pregnant women with confirmed
2009 H1N1 nfection admitted to Australian and New
Zealand intensive care units during the winter of 2009.
METHODS
Using the Australian and New Zealand Intensive Care
(ANZIC) Influenza Investigators registry,7 we identi-
fied all women admitted to an intensive care unit
between 1 June and 31 August 2009 with confirmed
2009 H1N1 infection who were either pregnant or
post partum (completion of pregnancy within the past
28 days). All 187 intensive care units in Australia and
NewZealand have been screening patients for this reg-
istry, which documents all patients admitted to an
intensive care unit with confirmed influenza A.7 Regis-
try datawere last updated on 18November 2009.Defi-
nitions, including the diagnosis of H1N1 influenza,
secondary bacterial pneumonia, and other influenza
syndromes, have been described previously.7 We
report our findings according to strengthening the
reporting of observational studies in epidemiology
guidelines.9
Additional data on obstetric history,management of
the current pregnancy, and birth outcomes were col-
lected using the Australian Maternity Outcomes Sur-
veillance System and a case report form based on one
developed by the United Kingdom Obstetric Surveil-
lance System. We collected data on the mothers’
height and weight at time of booking for maternity ser-
vices, any coexisting illness, gravidity, parity (previous
pregnancies with a birth at ≥20 weeks’ gestation), esti-
mated date of delivery, plurality, miscarriage (fetal loss
before 20 weeks’ gestation), vaccination against seaso-
nal influenza during this pregnancy, and any medical
or obstetric problems that developed during the cur-
rent pregnancy. We documented the date and time of
delivery, the occurrence of labour and whether it was
spontaneous or induced, the indications for induction
of labour or surgical delivery (categorised as one or
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more of maternal hypoxia or difficult ventilation,
maternal haemodynamic instability, and fetal compro-
mise), the use of corticosteroids to induce fetal lung
maturation, and postpartum haemorrhage with more
than 1500ml of blood loss. For each baby we recorded
the method of birth (unassisted vaginal, assisted vagi-
nal, or surgical delivery), gestation, birth weight, live
born or stillborn (fetal death ≥20 completed weeks of
gestation), Apgar score at five minutes, admission and
duration of admission to a neonatal intensive care unit
or special care nursery, infant infection with 2009
H1N1 influenza, the occurrence of any complication,
and survival status at time of hospital discharge.Mater-
nal and neonatal outcomes were last updated on 22
February 2010 or last hospital discharge after delivery.
We estimated the population at risk from publicly
available data. As gestational status changes with
time, we considered the unit of risk to be each week
of gestation from conception to four weeks post par-
tum. From the most recently available registrations of
births and stillbirths we estimated the prevalence of
pregnant women at 20 weeks or more of gestation or
who were post partum, between 1 June and 31 August,
after adjustment for multiple births and preterm deliv-
ery, as reported by the Australian Bureau of Statistics
and Statistics New Zealand.10-12 We estimated the
prevalence of pregnant women at less than 20 weeks
of gestation using the same most recently available
registrations of births and stillbirths, with the addition
of pregnant women who had therapeutic or sponta-
neous abortions or an ectopic pregnancy.We obtained
the number of women who had therapeutic abortions
from registrations in New Zealand13 and from pub-
lished estimates in Australia.14 The number of preg-
nant women who have a spontaneous abortion
between six and 20 weeks after the last menstrual per-
iod was estimated to be 10.9% of all pregnancies and
the ectopic pregnancy rate was estimated to be 2.3%,
with allowance for estimated gestation at the time of
fetal loss.15 No additional allowance was made for
pregnancy loss less than six weeks after the last men-
strual period. We determined the population of
women of childbearing age (15-44 years) in 2008 in
Australia16 and 2009 in New Zealand.17 We obtained
the annual number of births in Aboriginal and Torres
Strait Islanderwomen and the total number of births in
Australia 2008 from the Australian Bureau of
Statistics.18 The number of births in Maori or Pacific
Islander women and the total number of births in
New Zealand in 2007 were obtained from the New
Zealand Ministry of Health.19
Statistical analysis
Weanalysed thedata usingSPSS forWindows, version
17.0. We calculated descriptive statistics for all study
variables. We report continuous variables as medians
(ranges) and categorical variables as percentages or
relative risk ratios (95% confidence intervals), where
appropriate.
RESULTS
During the study period, 209 women of childbearing
age (15-44 years) were admitted to an intensive care
unit with confirmed 2009 H1N1 infection. Of these,
64 (31%) were either pregnant or post partum; 57
were admitted to an intensive care unit in Australia
and seven to an intensive care unit in New Zealand.
At the time of onset of symptoms of influenza, 10 of
these 64 women were at less than 20 weeks’ gestation,
49 were at 20 weeks or more, and five were post par-
tum. The estimated number of women of childbearing
age in Australia and New Zealand during the study
period was 5 426 000, giving 70 533 000 women
weeks—that is, weeks of potential pregnancy over the
13 weeks of the pandemic. Overall, there were
1 899 000 women weeks of gestation at less than
20 weeks, 1 704 000 women weeks of gestation at
20weeks ormore, and 358 000womenweeks post par-
tum.
The overall risk of admission to an intensive care
unit for non-pregnant women of childbearing age was
1 in 35 300 compared with 1 in 14 600 for gestations
less than 20 weeks, 1 in 2700 for gestations of
20 weeks or more, and 1 in 5500 for the postpartum
period. Comparedwith non-pregnant women of child-
bearing age, pregnant women with a gestation of
20 weeks or more had a 13-fold greater risk of
Discharged with ongoing pregnancy (n=26)Delivered while in intensive care unit (n=14):
  Stillbirth (n=1)
  Liveborn babies (includes set of twins) (n=14)
  Maternal deaths (n=3)
Pregnant or postpartum women admitted to intensive care unit with 2009 H1N1 infection (n=64)
Presumed delivered but lost to follow-up
(at last follow-up on 22 February 2010) (n=3)
Delivered after discharge (n=23):
  Stillbirth (n=1)
  Liveborn babies (n=22)
Pregnant on admission (n=40) Post partum on admission (n=22) Miscarried (n=2)
Stillbirths (n=2)
Liveborn babies (n=20)
  (3 subsequent infant deaths)
Maternal deaths (n=3)
Maternal death (n=1)
Fig 1 | Outcomes after admission to intensive care unit
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Fig 2 | Gestation at onset of influenza symptoms in women, according to pregnancy status
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admission to an intensive care unit as a result of 2009
H1N1 infection (relative risk 13.2, 95% confidence
interval 9.6 to 18.3). The corresponding risk for post-
partum women was 6.4 (2.6 to 15.7) and for women
with a gestation of less than 20 weeks was 2.4 (1.3 to
4.6). Overall, compared with non-pregnant women of
childbearing age the relative risk of women who were
pregnant or post partumbeing admitted to an intensive
care unit with 2009 H1N1 infection was 7.4 (5.5 to
10.0).
Figure 1 summarises the maternal and perinatal out-
comes after admission to an intensive care unit. Of the
64 women admitted to an intensive care unit, 40 (63%)
were pregnant, 22 (34%) were post partum, and 2 (3%)
had miscarried. Twenty six women (41%) were dis-
charged from the intensive care unit with ongoing
pregnancy, of whom 23 (36%) had given birth at last
follow-up. Three women should have delivered
according to dates but could not be followed up as of
22 February 2010. Admission to an intensive care unit
post partum or after miscarriage occurred a median of
0 (range 0-8) days after delivery, and 19 of 24 women
(79%) had onset of influenza symptoms while preg-
nant. Figure 2 shows the duration of gestation at onset
of influenza symptoms for women categorised as hav-
ing had a miscarriage, being post partum at admission
to an intensive care unit, deliveringwhile in the unit, or
being discharged from the unit with an ongoing preg-
nancy.
Tables 1 and 2 list the characteristics, influenza syn-
dromes and onset of symptoms, management in inten-
sive care, and outcome of pregnant or postpartum
women admitted to an intensive care unit with 2009
H1N1 infection. Thirteen of 57 patients (20%) in Aus-
traliawereAustralianAboriginal orTorres Strait Islan-
ders. Admission to an intensive care unit was more
common in this group than in non-indigenous
women (relative risk 6.2, 95% confidence interval 3.8
to 9.9). Admission to an intensive care unit was also
more common among Maori and Pacific Islander
women compared with other pregnant women (2.3,
1.4 to 3.7). Of 59 women with available data, 25
(39%) had a body mass index of more than 30 and 13
(20%) an index or more than 35. Overall, 36 women
(56%) had a documented coexisting illness, of whom
21 (33%of total) had asthma.Other coexisting illnesses
included documented valvular or congenital heart dis-
ease in fourwomen (6%), depression requiring drugs in
three (5%), and diabetes and essential hypertension in
two women (3%). Sixteen women (25%) developed a
new obstetric problem during their pregnancy, of
whom six (9%) developed gestational diabetes and
seven (11%) pregnancy induced hypertension or pre-
eclampsia. No women had been immunised against
seasonal influenza.
Forty four women (69%) were mechanically venti-
lated for a median of nine days (range 1-45 days), and
nine (14%) were treated with extracorporeal mem-
brane oxygenation. Eighteen women (28%) received
corticosteroids for reasons other than fetal lung
maturation and 81% received oseltamivir in the
intensive care unit (no other neuraminidase inhibitors
were used).
Seven women (11%) died from 2009 H1N1 influ-
enza. All seven had viral pneumonitis or acute respira-
tory distress syndrome secondary to 2009 H1N1
infection. In addition, two had pulmonary haemor-
rhage andone eachhad septic shock, viral encephalitis,
and the syndrome of haemolysis, elevated liver
enzymes, and lowplatelets.Allweremechanically ven-
tilated and three were treated with extracorporeal
membrane oxygenation. Four received corticoster-
oids. All were treated with oseltamivir. Six of the nine
Table 1 | Characteristics of pregnant or postpartum women
admitted to intensive care units with 2009 H1N1 infection.
Values are numbers (percentages) unless stated otherwise
Characteristics
Pregnant or postpartum
women
Age (years) at admission to intensive care
unit:
n=64
Median (range) 27 (16-42)
<20 7 (11)
20-34 41 (64)
≥35 16 (25)
Ethnicity:
White 37 (58)
Aboriginal or Torres Strait Islanders 13 (20)
Maori or Pacific Islanders 8 (13)
Other 6 (9)
Gravidity: n=63
1 15 (24)
2-4 33 (52)
>5 15 (24)
Parity: n=63
Nulliparous 19 (30)
1 previous 19 (30)
≥2 previous 25 (40)
Body mass index (kg/m2): n=59
<25.0 19 (32)
25.0-29.9 15 (25)
30.0-34.9 12 (20)
≥35.0 13 (22)
Documented coexisting illness
Present: 36 (56)
Asthma 21 (33)
Valvular or congenital heart disease 4 (6)
Depression (receiving treatment) 3 (5)
Diabetes 2 (3)
Essential hypertension 2 (3)
Absent 28 (44)
Onset of any new obstetrical problem
during pregnancy*:
16 (25)
Gestational diabetes 6 (9)
Pregnancy induced hypertension or pre-
eclampsia
7 (11)
Chorioamnionitis 2 (3)
Other problem 3 (5)
*Some women had more than one obstetrical problem.
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women (67%) treated with extracorporeal membrane
oxygenation survived.
As of 22 February 2010, 59 of the women were
known to have given birth to 60 babies of at least
20 weeks’ gestation; 56 were live born and four were
stillbirths. There was one set of liveborn twins. Of the
22 postpartum women, 14 (64%) had had an emer-
gency caesarean section and eight (36%) had sponta-
neous vaginal deliveries. Fourteen women (26%)
gave birth during their stay in an intensive care unit,
13 (93%) by emergency caesarean section. Non-
mutually exclusive indications for delivery that
occurred in women while in an intensive care unit
were maternal hypoxaemia in 13 (93%), maternal hae-
modynamic instability in 8 (57%), and concern for fetal
wellbeing in 3 (21%). Three of the 14 women (21%)
requiring caesarean section while in the intensive
care unit died. In only one case was concern for fetal
wellbeing the sole indication for delivery while in the
intensive care unit. Of 23 women who delivered after
discharge from intensive care, 17 (74%) had vaginal
deliveries and six (26%) caesarean sections, of which
three were elective and three were during labour.
Seven women (16%) had postpartum haemorrhage
(blood loss >1500 ml).
Table 3 describes the perinatal outcomes of the 60
babies. Eleven (18%) had gestations between 32 and
37 weeks, and 11 (18%) between 20 and 32 weeks.
Ten (17%) weighed between 1500 g and 2500 g at
birth, whereas eight (13%) weighed less than 1500 g.
The birth weight of three male neonates (5%) was
below the 10th centile for gestational age for males.
Thirty two (57% of 56 liveborn babies) were admitted
to a neonatal intensive care unit or special care nursery,
including three babies born after the mother was dis-
charged from the intensive care unit, for a median stay
of 18 days (range 1-79 days). Twenty one (38% of 56
liveborn babies) required continuous positive airway
pressure ventilation or endotracheal intubation with
positive pressure ventilation. Of 20 neonates tested,
two were positive for 2009 H1N1 virus infection.
Three infants died (two neonates and one post-neona-
tal infant), all related to complications of prematurity,
hypoxic encephalopathy, or both.
DISCUSSION
Pregnancy is a risk factor for 2009 H1N1 related criti-
cal illness. Of the 64 pregnant and postpartum women
who were admitted to an intensive care unit in Austra-
lia andNewZealandwith confirmed2009H1N1 infec-
tion, the risk of critical illness was much greater later in
the pregnancy, at over 13 times the risk in the non-
pregnant population. 2009 H1N1 infection was asso-
ciated with substantial maternal and perinatal morbid-
ity and mortality.
Our results show that indigenous pregnant women
in Australia and New Zealand were at higher risk of
critical illness due to 2009 H1N1 influenza than non-
indigenous pregnant women, consistent with the
observation that women from indigenous populations
are at higher risk for a variety of complications of preg-
nancy associated with poor maternal and neonatal
outcomes.20-22Over half of thewomen had a coexisting
illness. Pre-existing asthma occurred in 21% of these
women compared with 12% in the general Australian
birthing population.23 Among the critically ill women,
42% had a body mass index of more than 30 and 22%
of more than 35; the corresponding proportions in the
Australian birthing population are 24% and 10%.24
This is consistent with a preliminary report that identi-
fies obesity as a risk factor for 2009 H1N1 related cri-
tical illness in pregnant women in the United
Kingdom.25
Most of thewomenadmitted to an intensive care unit
were treated with mechanical ventilation and 14%
were treated with extracorporeal membrane
oxygenation.26 As seen in the general intensive care
unit population, severe 2009 H1N1 infection was pre-
dominantly single system respiratory failure with only
a few women requiring support for multiorgan failure.
The time from the onset of symptoms to the receipt of
antiviralswas long formanyof thewomen in this study,
with antiviral drugs started a median of six days after
Table 2 | Influenza syndromes and onset of symptoms, intensive care management, and
outcome of pregnant or postpartum women admitted to intensive care unit with 2009 H1N1
infection. Values are numbers (percentages) unless stated otherwise
Variables Pregnant or postpartum women (n=64)
Influenza syndrome:
Viral pneumonitis or acute respiratory distress syndrome 35 (55)
Secondary bacterial pneumonia 18 (28)
Asthma or exacerbation of chronic obstructive pulmonary
disease
6 (9)
Intercurrent infection 5 (8)
Median (range) interval from onset of symptoms to admission to
intensive care unit (days)
6 (0-35)
Median (range) interval from onset of symptoms to first positive
test result for 2009 H1N1 (days)
5 (1-39)
Median (range) gestation at onset of symptoms of influenza
(weeks):
<20 16 (8-19)
≥20 31 (20-40)
Median (range) gestation at time of admission to intensive care
unit, or delivery if post partum (weeks):
Total cohort 31 (8-41)
Pregnant 29 (14-38)
Post partum 38 (26-41)
Treatment in intensive care unit:
Invasive mechanical ventilation 44 (69)
Median (range) duration of ventilation (days) 9 (1-45)
Extracorporeal membrane oxygenation 9 (14.1)
Renal replacement therapy 5 (8)
Vasopressors 22 (34)
Antiviral drugs 52 (81)
Median (range) duration of antiviral treatment (days) 5 (0-22)
Corticosteroids prescribed for fetal lung maturation (n=44) 15 (34)
Corticosteroids for any maternal indication 20 (31)
Median (range) interval from symptom onset to antiviral treatment
(days)
6 (0-37)
Median (range) duration of stay in intensive care unit 8 (1-50)
Died in intensive care unit 7 (11)
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onset of symptoms. The recommended timing for
starting antiviral treatment is less than 48 hours from
the onset of symptoms.27 Whether earlier treatment
with an antiviral agent could have modified the sever-
ity of illness is unknown.
Overall, seven women (11%) died. Generally, influ-
enza has been an extremely rare cause of maternal
death. Between 1997 and 2005 in Australia, 24 mater-
nal deaths occurred as a result of any infection, or 1.1
deaths per 100 000 births.21 28 29 Only one of these
deaths was due to influenza.29 No maternal deaths
were attributed to influenza in the United Kingdom
between 1997 and 2005.30-32 Other descriptions of
2009 H1N1 influenza during pregnancy in the United
States have also documented substantial mortality,
including an 8% mortality among pregnant women
with severe 2009 H1N1 infection in California.6 8
Although a mortality of 11% seems low when com-
pared with usual outcomes of respiratory failure in
intensive care (such as 30-40% mortality for the acute
respiratory distress syndrome in a general intensive
care population),33 a maternal mortality of 11% is
high when compared with any other obstetric condi-
tion.
Operative births and preterm delivery were com-
mon. Most of the caesarean sections were carried out
for maternal hypoxia or haemodynamic instability.
Concern for the fetus was the primary indication for
only one delivery. The proportion of women who
had a caesarean section before or during their stay in
an intensive care unit was 75%, comparedwith 30% for
the general birthing population in Australia.20 Caesar-
ean delivery for maternal hypoxia has generally not
been recommended in the literature as it has been
thought not to improve maternal outcome,34 but in
our series only three (21%) of these women died
despite critical hypoxaemia.
No woman in this cohort had been immunised
against seasonal influenza despite established recom-
mendations that pregnant women should be
immunised.35 A specific 2009 H1N1 vaccine has
recently been made available and is recommended
for pregnant women.35 36 The availability ofH1N1 vac-
cine and antiviral treatment may modify the epide-
miology and alter the course of the disease in the
future.
Infection with 2009 H1N1 had a substantial impact
on neonatal outcomes. Most neonates born to the cri-
tically ill women in this study were admitted to a neo-
natal intensive care unit or special care nursery,
compared with less than 15% of the total newborn
population in Australia.20 Few neonates were small
for gestational age, consistent with the acute onset of
the illness. Overall, seven perinatal deaths occurred,
four of them stillbirths. Whether earlier delivery in
women at over 30 weeks’ gestation with severe disease
could improve neonatal outcome is currently
unknown.
Strengths and limitations of the study
This studywas population based and, to the best of our
knowledge, included all pregnant or postpartum
womanwith confirmed 2009H1N1 infection admitted
to any intensive care unit in Australia and New Zeal-
and.Overall, our numbers were small, which limits the
conclusions that can be drawn. The incidence, infec-
tion rate, and virulence of influenza infection may be
different at other locations and at different stages of the
pandemic, and this may limit generalisability.
Conclusion
Pregnant women, particularly in the second half of
pregnancy, are more likely than non-pregnant
women to develop critical illness associated with
2009H1N1 influenza. Among womenwho developed
critical illness, the outcomes were poor, including
death of the mother or baby.
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Median (range) 2806 (640-4260)
1500 to 2499 10 (17)
<1500 8 (13)
Apgar score <4 at five minutes 8 (13)
Admission toNICUorSCN (of 56 liveborns) 32 (57)
Use of assisted ventilation in NICU or SCN
(n=32):
None 11 (34)
Continuous positive airway pressure
ventilation only
5 (16)
Endotracheal intubation or ventilation 16 (50)
Median (range) duration of admission to
NICU or SCN (days)
18 (1-79)
Documented infection with 2009 H1N1† 2 (10)
Hospital outcome:
Still birth 4 (7)
Discharged 53 (88)
Infant death‡ 3 (5)
NICU=neonatal intensive care unit; SCN=special care nursery.
*Includes one set of twins. Denominators vary.
†Of 20 babies tested.
‡Two neonatal and one post-neonatal.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Pregnant women are at an increased risk of complications from influenza
Other risk factors include obesity and respiratory problems such as asthma
WHAT THIS STUDY ADDS
A disproportionate number of pregnant or postpartum women were admitted to intensive
care with 2009 H1N1 influenza, particularly after 20 weeks’ gestation
Overall, 11% of mothers and 12% of babies died
Intensive management for maternal hypoxia, including caesarean section and extracorporeal
membrane oxygenation, led to better than expected outcomes
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